Literature DB >> 19201851

A defect in Marco expression contributes to systemic lupus erythematosus development via failure to clear apoptotic cells.

Nicola Jane Rogers1, Mark Jeffrey Lees, Luisa Gabriel, Eleni Maniati, Sarah Jane Rose, Paul Keith Potter, Bernard John Morley.   

Abstract

Systemic lupus erythematosus is a multisystem autoimmune disease characterized by the production of numerous antinuclear autoantibodies and inflammatory mediators. The BXSB mouse strain is an excellent model of the disease. Previous work has determined a number of important disease susceptibility intervals that have been isolated in separate congenic strains. Here, we have combined expression data from those strains with functional analyses to demonstrate that reduced expression of the innate scavenger receptor Marco (macrophage receptor with collagenous structure) is a primary event in BXSB mice, that reduced mRNA expression is mirrored at the protein level, and that this results in a significant alteration in function. We have confirmed a role for Marco in the clearance of apoptotic cells and a generalized defect in both endocytosis and phagocytosis. The failure to clear apoptotic cells has previously been linked to the development of systemic lupus erythematosus. However, the use of congenic mice with limited phenotypes in this study has enabled us to propose that in the case of Marco at least, disease results from the production of anti-dsDNA Abs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201851     DOI: 10.4049/jimmunol.0801320

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

Review 1.  Genetics of SLE: evidence from mouse models.

Authors:  Laurence Morel
Journal:  Nat Rev Rheumatol       Date:  2010-05-04       Impact factor: 20.543

Review 2.  Contributions of B cells to lupus pathogenesis.

Authors:  Allison Sang; Ying-Yi Zheng; Laurence Morel
Journal:  Mol Immunol       Date:  2013-12-12       Impact factor: 4.407

3.  A Novel Subset of Anti-Inflammatory CD138+ Macrophages Is Deficient in Mice with Experimental Lupus.

Authors:  Shuhong Han; Haoyang Zhuang; Stepan Shumyak; Jingfan Wu; Hui Li; Li-Jun Yang; Westley H Reeves
Journal:  J Immunol       Date:  2017-07-10       Impact factor: 5.422

4.  Ethanol intoxication prolongs post-burn pulmonary inflammation: role of alveolar macrophages.

Authors:  Jill A Shults; Brenda J Curtis; Devin M Boe; Luis Ramirez; Elizabeth J Kovacs
Journal:  J Leukoc Biol       Date:  2016-08-16       Impact factor: 4.962

Review 5.  Autophagy in autoimmune disease.

Authors:  Zhen Yang; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Mol Med (Berl)       Date:  2015-06-10       Impact factor: 4.599

6.  The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease.

Authors:  M M Harnett; A J Melendez; W Harnett
Journal:  Clin Exp Immunol       Date:  2009-12-01       Impact factor: 4.330

7.  The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells.

Authors:  Wen-Hai Shao; Yuxuan Zhen; Robert A Eisenberg; Philip L Cohen
Journal:  Clin Immunol       Date:  2009-07-24       Impact factor: 3.969

Review 8.  Toxicology of autoimmune diseases.

Authors:  K Michael Pollard; Per Hultman; Dwight H Kono
Journal:  Chem Res Toxicol       Date:  2010-03-15       Impact factor: 3.739

9.  Hematopoietic stem and multipotent progenitor cells produce IL-17, IL-21 and other cytokines in response to TLR signals associated with late apoptotic products and augment memory Th17 and Tc17 cells in the bone marrow of normal and lupus mice.

Authors:  Ching-I Chen; Li Zhang; Syamal K Datta
Journal:  Clin Immunol       Date:  2015-10-28       Impact factor: 3.969

10.  Autophagy regulates phagocytosis by modulating the expression of scavenger receptors.

Authors:  Diana L Bonilla; Abhisek Bhattacharya; Youbao Sha; Yi Xu; Qian Xiang; Arshad Kan; Chinnaswamy Jagannath; Masaaki Komatsu; N Tony Eissa
Journal:  Immunity       Date:  2013-09-12       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.